Dangerous Drug Lawsuits










Jury Awards $70 Million in Risperdal Trial

In early July, a jury in a Philadelphia courtroom awarded $70 million to the family of a boy who developed breasts after taking the antipsychotic drug Risperdal. The jury found that the maker of Risperdal, Janssen Pharmaceuticals, failed to warn the boy’s healthcare providers that there was a risk... click to read more





J&J’s Baby Powder Problem

Bloomberg released an investigatory report regarding the potential link between long term use of talcum powder in the genital area and ovarian cancer in women. J&J has been selling its Baby Powder for over 100 years, yet there had never been a discussion concerning ovarian cancer until a British... click to read more



Troubling Allegations in Risperdal Trial

The most troubling aspect of a recent case decided against Johnson & Johnson (J&J) concerning its antipsychotic drug Risperdal is the allegation that the company deliberately withheld data from the U.S. Food and Drug Administration. An expert witness testified that J&J knew about the risk of gynecomastia associated with... click to read more



Jury Awards $2.5 Million in Risperdal Trial

The Wall Street Journal reported that a Philadelphia jury held Johnson & Johnson (J&J) liable for failing to warn that its antipsychotic drug Risperdal could cause gynecomastia and ordered the company to pay $2.5 million in damages. The family of an autistic boy who took Risperdal between 2002 and... click to read more



FDA Warns of Ketoacidosis with Certain Diabetes Drugs

An article on the American Academy of Family Physicians’ website discussed the FDA’s recent move to add warnings to the labels of diabetes drugs like Invokana to notify users about the potential risk of ketoacidosis. The article also cautioned physicians whose patients are on these diabetes drugs to watch... click to read more



No Legal Recourse for Injuries from Generic Drugs

When a person suffers injuries from a generic drug, there may be no recourse in a court of law. Unfortunately, one Massachusetts family had to discover this the hard way. A report done by a local CBS affiliate on the Steele family illustrates how patients taking generic drugs could... click to read more



Innovator Liability in Massachusetts

After reading this article I wanted to see how Massachusetts’ courts had ruled on the issue of innovator liability. A majority of them found that brand name manufacturers were not liable for injuries caused by use of their identical generic versions. The courts’ reasoning seemed to be summed up... click to read more



Xarelto Reversal Agent in Late Stage Trial

A drug developed to rapidly reverse the effect of new blood thinners during episodes of major bleeding has been effective in late stage trials according to an article on Reuters.com. The drug reportedly reversed the anticoagulant effect of the new blood thinners, including Xarelto, with no serious side effects... click to read more



top